Source: Essentially Sports
The National Bank Open in Toronto is facing significant backlash due to its partnership with Ozempic, a medication used for diabetes management that has gained attention for its weight loss effects. Fans have voiced their concerns about the presence of Ozempic branding prominently displayed around the stadium, which they feel detracts from the focus on tennis. The controversy has sparked discussions about the appropriateness of such partnerships in sports, particularly in a setting where health and wellness are paramount. As the tournament continues, organizers will need to navigate the fallout from this backlash while ensuring that the focus remains on the athletes and their performances.
